|
News Advisory
NCI Creates Network
of Clinical Proteomic Technology Centers for Cancer Research
|
| What: |
Clinical Proteomic Technology Assessment
for Cancer teams
The National Cancer Institute (NCI), part of the
National Institutes of Health, will host a telebriefing
to announce five Clinical Proteomic Technology Assessment
for Cancer (CPTAC) teams. A major component of its $104
million, five-year Clinical Proteomics Technologies Initiative,
the CPTAC awards total $35.5 million over five years.
The CPTAC teams will bring complementary expertise to
assess the full spectrum of measurement technologies for
proteins and peptides relevant to clinical cancer research
and practice. The network’s collaborative efforts will
guide and provide resources to the broader cancer research
community, enabling researchers conducting cancer-related
protein research at different laboratories to use proteomic
technologies and methodologies to directly compare their
work. Standardized technologies and methodologies are critically
needed in current cancer proteomic research. |
| Who: |
Anna D. Barker, Ph.D., NCI
deputy director, advanced technologies and strategic partnerships
Lee Hartwell, Ph.D., president and director, Fred
Hutchinson Cancer Research Center
Steven A. Carr, Ph.D., Broad Institute of MIT and
Harvard
Joe Gray, Ph.D.,University of California, San Francisco/Lawrence
Berkeley National Laboratory
Daniel C. Liebler, Ph.D., Vanderbilt University
School of Medicine
Fred E. Regnier, Ph.D., Purdue University
Paul Tempst, Ph.D., Memorial Sloan-Kettering Cancer
Center |
| When: |
Wednesday, September 27, 2006 1:00
p.m. - 2:00 p.m. EDT
The media briefing is available to reporters via a toll-free
conference line at
1-866-755-5928 (Teleconference number: 7211683) in the United
States only. |
| Note: |
The briefing will begin promptly at 11:00
a.m. EDT. Reporters should dial in 5-10 minutes before the
start of the conference. Following the presentations, an
operator will inform you that the session is open to questions.
To ask a question, press *1 on your touchtone phone. You
will hear a tone to indicate your question is pending. A
transcript of the briefing will be available as soon as possible
following the briefing at http://proteomics.cancer.gov. |
|
The National Institutes of Health (NIH) — The Nation's Medical
Research Agency — includes 27 Institutes and Centers and
is a component of the U.S. Department of Health and Human Services.
It is the primary federal agency for conducting and supporting basic,
clinical and translational medical research, and it investigates the
causes, treatments, and cures for both common and rare diseases. For
more information about NIH and its programs, visit www.nih.gov.
|
